Super League Enterprise, Inc. (SLE)

NCM – Real Time Price. Currency in USD

4.15

+0.02 (0.48%)

At close: May 12, 2026, 4:00 PM EDT

4.01

-0.14 (-3.37%)

After-hours: May 12, 2026, 7:45 PM EDT

06.05.2026

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

SANTA MONICA, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company trusted by global brands to reach and engage people who play video games across the digital advertising landscape, today announced the closing of its previously announced acquisition of the Misfits Ads Division from Misfits Gaming Group.

05.05.2026

Super League Sets First Quarter 2026 Earnings Date, May 15, 2026

SANTA MONICA, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company trusted by global brands to reach and influence people who play video games across the digital landscape, announced today that the Company will post its first quarter 2026 financial results before market open on Friday, May 15, 2026.

30.04.2026

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that clinical data from the Company's off-the-shelf CAR T-cell product candidate, FT819, will be featured at the Congress of Clinical Rheumatology – East meeting, being held in Destin, FL on April 30 - May 3, 2026. The Company is participating in a Poster Rounding Session and will present an encore of its clinical data from the systemic lupus erythematosus (SLE) study arm of its ongoing Phase 1 trial evaluating FT819 in various autoimmune diseases.

20.04.2026

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Transaction will add pro-forma profitable revenue, enhance predictability of financial performance, expand market share, and accelerate the Company's path to sustainable cash-based EBITDA profitability. Management encourages Shareholders to vote in favor of the proposal.

09.04.2026

Super League Acquires Stake in Top Roblox Experience, My Avatar!

SANTA MONICA, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Super League, an audience intelligence and media activation company trusted by global brands to reach and engage people who play video games across the digital advertising landscape, today announced it has acquired an ownership interest in My Avatar!

27.03.2026

Super League Enterprise, Inc. (SLE) Q4 2025 Earnings Call Transcript

27.03.2026

Super League Enterprise (SLE) Reports Q4 Loss, Misses Revenue Estimates

Super League Enterprise (SLE) came out with a quarterly loss of $9.44 per share versus the Zacks Consensus Estimate of a loss of $3.12. This compares to a loss of $216.09 per share a year ago.

Videos

No Data

There is no data to display

Press releases

06.05.2026

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

30.04.2026

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

20.04.2026

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

09.04.2026

Super League Enterprise, Inc. (SLE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Super League Enterprise, Inc. (SLE)

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

Super League Sets First Quarter 2026 Earnings Date, May 15, 2026

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Acquires Stake in Top Roblox Experience, My Avatar!

Super League Enterprise, Inc. (SLE) Q4 2025 Earnings Call Transcript

Super League Enterprise (SLE) Reports Q4 Loss, Misses Revenue Estimates

Videos

No Data

Press releases

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Acquires Stake in Top Roblox Experience, My Avatar!

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

Super League Sets First Quarter 2026 Earnings Date, May 15, 2026

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Acquires Stake in Top Roblox Experience, My Avatar!

Super League Enterprise, Inc. (SLE) Q4 2025 Earnings Call Transcript

Super League Enterprise (SLE) Reports Q4 Loss, Misses Revenue Estimates

Videos

No Data

Press releases

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Acquires Stake in Top Roblox Experience, My Avatar!

Search stocks

Super League Enterprise, Inc. (SLE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Super League Enterprise, Inc. (SLE)

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

Super League Sets First Quarter 2026 Earnings Date, May 15, 2026

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Acquires Stake in Top Roblox Experience, My Avatar!

Super League Enterprise, Inc. (SLE) Q4 2025 Earnings Call Transcript

Super League Enterprise (SLE) Reports Q4 Loss, Misses Revenue Estimates

Videos

No Data

Press releases

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Acquires Stake in Top Roblox Experience, My Avatar!

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

Super League Sets First Quarter 2026 Earnings Date, May 15, 2026

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Acquires Stake in Top Roblox Experience, My Avatar!

Super League Enterprise, Inc. (SLE) Q4 2025 Earnings Call Transcript

Super League Enterprise (SLE) Reports Q4 Loss, Misses Revenue Estimates

Videos

No Data

Press releases

Super League Completes Acquisition of Misfits Ads Division, Strengthening Revenue Foundation and Advancing Path to Profitability

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Acquires Stake in Top Roblox Experience, My Avatar!